// company-profile

Coherus Oncology, Inc.

CHRS
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings73Insiders15
// api This Coherus Oncology, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 29 insiders purchased shares versus 15 sales. Buying was led by Newton Charles W..

// 90-day insight

Over the last 90 days, Coherus Oncology, Inc. insiders bought $0 (29 transactions) and sold $0 (15 transactions).

  • Most active insider: Lanfear Dennis M with 18 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Coherus Oncology, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$93.2M
QoQ change
+72.0%
Reporting period
2026-03-31
#1
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$9.2M
5.5M shares
#2
BlackRock, Inc.
CIK 2012383
$7.2M
4.3M shares
#3
BlackRock, Inc.
CIK 2012383
$6.2M
3.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 5, 2026Newton Charles W.CHRS
Award
60,000$0.00$0K
Jun 5, 2026Newcomer Lee NisleyCHRS
Award
30,000$0.00$0K
Jun 5, 2026O'Donnell-Tormey JillCHRS
Award
30,000$0.00$0K
Jun 5, 2026Karachun Rita ACHRS
Award
60,000$0.00$0K
Jun 5, 2026Satvat Ali J.CHRS
Award
60,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.